カテゴリ： Bizwit Research & Consulting, 世界, 医療/バイオ

白血球除去のグローバル市場（2022年-2029年）：白血球除去装置、白血球除去用使い捨て器具

■ 英語タイトル：Global Leukapheresis Market Size study & Forecast, by Product Type (Leukapheresis Devices, Leukapheresis Disposables), by Application (Research Applications, Therapeutic Applications), by End-User (Hospitals & Transfusion Centers, Component Providers & Blood Centers, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies) and Regional Analysis, 2022-2029

調査会社Bizwit Research & Consulting社が発行したリサーチレポート（データ管理コード：BZW23MA006）■ 発行会社/調査会社：Bizwit Research & Consulting
■ 商品コード：BZW23MA006
■ 発行日：2023年4月17日
■ 調査対象地域：アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東
■ 産業分野：医療
■ ページ数：約200
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用、印刷不可）USD4,950 ⇒換算￥752,400見積依頼/購入/質問フォーム
Enterprisewide（同一法人内共有可）USD6,250 ⇒換算￥950,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Bizwit Research & Consulting社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[白血球除去のグローバル市場（2022年-2029年）：白血球除去装置、白血球除去用使い捨て器具]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Bizwit Research社の本調査資料によると、2021年にXXX億ドルであった世界の白血球除去市場規模が、予測期間中（2022年〜2029年）に年平均XXX%で成長すると予想されています。本資料は、白血球除去の世界市場にフォーカスし、市場状況や今後の展望についてまとめており、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、リスク分析（新型コロナウイルス感染症の影響）、製品別（白血球除去装置、白血球除去用使い捨て器具）分析、用途別（研究用、治療用）分析、エンドユーザー別（病院・輸血センター、コンポーネントプロバイダー＆血液センター、学術・研究機関、製薬・バイオテクノロジー企業）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、その他地域）分析、競争分析、調査プロセスなどを掲載しています。本書は、主要企業として、Asahi Kasei Corporation (Japan)、Fresenius SE & Co. KGaA (Germany)、Haemonetics Corporation (US)、Terumo BCT (US)、Macopharma SA (France)、Miltenyi Biotec (Germany)、Guangzhou Daji Medical Science and Technology Co. Ltd. (China)、MEDICA S.p.A (Italy)、PuriBlood Medical Co. Ltd. (Taiwan)、Beijing ZKSK Technology Co. Ltd. (China)などの情報が含まれています。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・リスク分析（新型コロナウイルス感染症の影響）
・世界の白血球除去市場規模：製品別
- 白血球除去装置の市場規模
- 白血球除去用使い捨て器具の市場規模
・世界の白血球除去市場規模：用途別
- 研究における市場規模
- 治療における市場規模
・世界の白血球除去市場規模：エンドユーザー別
- 病院・輸血センターにおける市場規模
- コンポーネントプロバイダー＆血液センターにおける市場規模
- 学術・研究機関における市場規模
- 製薬・バイオテクノロジー企業における市場規模
・世界の白血球除去市場規模：地域別
- 北米の白血球除去市場規模
- ヨーロッパの白血球除去市場規模
- アジア太平洋の白血球除去市場規模
- 中南米の白血球除去市場規模
- その他地域の白血球除去市場規模
・競争分析
・調査プロセス

Global Leukapheresis Market is valued at approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XXX% over the forecast period 2022-2029. Leukapheresis is used in the treatment of leukaemia or patients with high white blood cells. White blood cell levels in hematopoietic cells, such as persistent leukaemias, may be high enough to result in leukostasis. Changes in eyesight, shortness of breath due to less effective oxygen exchange, and other organ systems may be affected by this. Leukapheresis can therefore be carried out to collect the patient’s blood cells for a subsequent transplant. Rarely is leukapheresis—which is typically for granulocytes—performed during the blood donation process. The key factors driving the market growth are the rising number of blood donations and increasing demand for leukopaks in clinical research that is anticipated to create a lucrative demand for the market during forecast period.

Also, the growing incidence of leukemia is propelling the lucrative demand for the market. The International Agency for Research on Cancer (IARC) estimates that there were around 437,033 new cases of leukaemia worldwide in 2018 and that there were 309,006 leukemia-related deaths. Additionally, the rising number of blood donations is anticipated to drive market growth. The demand for blood and blood products is growing every year in many regions – particularly low- and middle-income countries. Blood and blood products assist intricate medical and surgical procedures, extend the lives of patients with life-threatening diseases, and improve their quality of life. The American National Red Cross 2020 estimates that around 21 million blood components are transplanted annually in the U.S. However, leukapheresis for pediatric patients creates a lucrative opportunity for the market. Also, the high cost of Therapeutic Leukapheresis stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Leukapheresis Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the dominating region across the world in terms of market share, owing to the presence of key players, rising prevalence of leukemia, and well-developed healthcare infrastructure. Whereas, Asia Pacific is also anticipated to exhibit the highest growth rate over the forecast period, owing to factors such as rise in prevalence of leukemia in this region, technological advancements, and rise in government initiatives to promote healthy lifestyles which would create lucrative growth prospects for the Leukapheresis market across Asia Pacific region.

Major market players included in this report are:
Asahi Kasei Corporation (Japan)
Fresenius SE & Co. KGaA (Germany)
Haemonetics Corporation (US)
Terumo BCT (US)
Macopharma SA (France)
Miltenyi Biotec (Germany)
Guangzhou Daji Medical Science and Technology Co. Ltd. (China)
MEDICA S.p.A (Italy)
PuriBlood Medical Co. Ltd. (Taiwan)
Beijing ZKSK Technology Co. Ltd. (China)

Recent Developments in the Market:
 In February 2022, Cryoport Inc. joined a partnership agreement with Cell Matters SA to deliver edge cryopreservation solutions for leukapheresis-derived therapies enabling both autologous and allogeneic cell treatments to the life sciences industry.

Global Leukapheresis Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product Type, Application, End-User, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type
Leukapheresis Devices
Leukapheresis Disposables

By Application:
Research Applications
Therapeutic Applications

By End-User:
Hospitals & Transfusion Centers
Component Providers & Blood Centers
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Leukapheresis Market, by Region, 2019-2029 (USD Billion)
1.2.2. Leukapheresis Market, by Product Type, 2019-2029 (USD Billion)
1.2.3. Leukapheresis Market, by Application, 2019-2029 (USD Billion)
1.2.4. Leukapheresis Market, by End-User, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Leukapheresis Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Leukapheresis Market Dynamics
3.1. Leukapheresis Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing incidence of leukemia
3.1.1.2. Rising number of blood donations
3.1.2. Market Challenges
3.1.2.1. High Cost of Therapeutic Leukapheresis
3.1.3. Market Opportunities
3.1.3.1. Leukapheresis for pediatric patients
Chapter 4. Global Leukapheresis Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Leukapheresis Market, by Product Type
6.1. Market Snapshot
6.2. Global Leukapheresis Market by Product Type, Performance – Potential Analysis
6.3. Global Leukapheresis Market Estimates & Forecasts by Product Type 2019-2029 (USD Billion)
6.4. Leukapheresis Market, Sub Segment Analysis
6.4.1. Leukapheresis Devices
6.4.2. Leukapheresis Disposables
Chapter 7. Global Leukapheresis Market, by Application
7.1. Market Snapshot
7.2. Global Leukapheresis Market by Application, Performance – Potential Analysis
7.3. Global Leukapheresis Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
7.4. Leukapheresis Market, Sub Segment Analysis
7.4.1. Research Applications
7.4.2. Therapeutic Applications
Chapter 8. Global Leukapheresis Market, by End-User
8.1. Market Snapshot
8.2. Global Leukapheresis Market by End-User, Performance – Potential Analysis
8.3. Global Leukapheresis Market Estimates & Forecasts by End-User 2019-2029 (USD Billion)
8.4. Leukapheresis Market, Sub Segment Analysis
8.4.1. Hospitals & Transfusion Centers
8.4.2. Component Providers & Blood Centers
8.4.3. Academic & Research Institutes
8.4.4. Pharmaceutical & Biotechnology Companies
Chapter 9. Global Leukapheresis Market, Regional Analysis
9.1. Leukapheresis Market, Regional Market Snapshot
9.2. North America Leukapheresis Market
9.2.1. U.S. Leukapheresis Market
9.2.1.1. Product Type breakdown estimates & forecasts, 2019-2029
9.2.1.2. Application breakdown estimates & forecasts, 2019-2029
9.2.1.3. End-User breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Leukapheresis Market
9.3. Europe Leukapheresis Market Snapshot
9.3.1. U.K. Leukapheresis Market
9.3.2. Germany Leukapheresis Market
9.3.3. France Leukapheresis Market
9.3.4. Spain Leukapheresis Market
9.3.5. Italy Leukapheresis Market
9.3.6. Rest of Europe Leukapheresis Market
9.4. Asia-Pacific Leukapheresis Market Snapshot
9.4.1. China Leukapheresis Market
9.4.2. India Leukapheresis Market
9.4.3. Japan Leukapheresis Market
9.4.4. Australia Leukapheresis Market
9.4.5. South Korea Leukapheresis Market
9.4.6. Rest of Asia Pacific Leukapheresis Market
9.5. Latin America Leukapheresis Market Snapshot
9.5.1. Brazil Leukapheresis Market
9.5.2. Mexico Leukapheresis Market
9.5.3. Rest of Latin America Leukapheresis Market
9.6. Rest of The World Leukapheresis Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Asahi Kasei Corporation (Japan)
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Fresenius SE & Co. KGaA (Germany)
10.2.3. Haemonetics Corporation (US)
10.2.4. Terumo BCT (US)
10.2.5. Macopharma SA (France)
10.2.6. Miltenyi Biotec (Germany)
10.2.7. Guangzhou Daji Medical Science and Technology Co. Ltd. (China)
10.2.8. MEDICA S.p.A (Italy)
10.2.9. PuriBlood Medical Co. Ltd. (Taiwan)
10.2.10. Beijing ZKSK Technology Co. Ltd. (China)
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

List of Tables
TABLE 1. Global Leukapheresis Market, report scope
TABLE 2. Global Leukapheresis Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Leukapheresis Market estimates & forecasts by Product Type 2019-2029 (USD Billion)
TABLE 4. Global Leukapheresis Market estimates & forecasts by Application 2019-2029 (USD Billion)
TABLE 5. Global Leukapheresis Market estimates & forecasts by End-User 2019-2029 (USD Billion)
TABLE 6. Global Leukapheresis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Leukapheresis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Leukapheresis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Leukapheresis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Leukapheresis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Leukapheresis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Leukapheresis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Leukapheresis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Leukapheresis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Leukapheresis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Leukapheresis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Leukapheresis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. U.S. Leukapheresis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. Canada Leukapheresis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 20. Canada Leukapheresis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. Canada Leukapheresis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. UK Leukapheresis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 23. UK Leukapheresis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. UK Leukapheresis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. Germany Leukapheresis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 26. Germany Leukapheresis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. Germany Leukapheresis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. France Leukapheresis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 29. France Leukapheresis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. France Leukapheresis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. Italy Leukapheresis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 32. Italy Leukapheresis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Italy Leukapheresis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Spain Leukapheresis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 35. Spain Leukapheresis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. Spain Leukapheresis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. RoE Leukapheresis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 38. RoE Leukapheresis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. RoE Leukapheresis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. China Leukapheresis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 41. China Leukapheresis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. China Leukapheresis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. India Leukapheresis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 44. India Leukapheresis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. India Leukapheresis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. Japan Leukapheresis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 47. Japan Leukapheresis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. Japan Leukapheresis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. South Korea Leukapheresis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 50. South Korea Leukapheresis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. South Korea Leukapheresis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. Australia Leukapheresis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 53. Australia Leukapheresis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. Australia Leukapheresis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. RoAPAC Leukapheresis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 56. RoAPAC Leukapheresis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. RoAPAC Leukapheresis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. Brazil Leukapheresis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 59. Brazil Leukapheresis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Brazil Leukapheresis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Mexico Leukapheresis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 62. Mexico Leukapheresis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. Mexico Leukapheresis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. RoLA Leukapheresis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 65. RoLA Leukapheresis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. RoLA Leukapheresis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. Row Leukapheresis Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 68. Row Leukapheresis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. Row Leukapheresis Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Leukapheresis Market
TABLE 71. List of primary sources, used in the study of global Leukapheresis Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 白血球除去のグローバル市場（2021〜2031）：装置、使い捨て製品
  • ニューロフォトニクスのグローバル市場（2022年-2029年）：顕微鏡、分光法、マルチモーダル
  • 超音波診断装置のグローバル市場（2022年-2029年）：小型、卓上型
  • 3Dバイオプリンティングのグローバル市場（2022年-2029年）：3Dバイオプリンター、バイオインク
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(BZW23MA006 )"白血球除去のグローバル市場（2022年-2029年）：白血球除去装置、白血球除去用使い捨て器具" (英文：Global Leukapheresis Market Size study & Forecast, by Product Type (Leukapheresis Devices, Leukapheresis Disposables), by Application (Research Applications, Therapeutic Applications), by End-User (Hospitals & Transfusion Centers, Component Providers & Blood Centers, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies) and Regional Analysis, 2022-2029)はBizwit Research & Consulting社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。